Peptide Semaglutide B6/BPC-157 is a compounded therapeutic combination of three unique agents: Semaglutide a GLP-1 receptor agonist that was initially developed to manage type 2 diabetes, but is now used for weight loss, is gaining attention
Semaglutide is a GLP-1R agonist approved for treatment of type 2 diabetes (in doses 0.5-2.0 mg once weekly) and obesity (2.4 mg once weekly) [6,7]
Available online at: July 8, 2020)
es: Agua carbonatada, cido ctrico, taurina 0.4%, citratos de sodio, aromas, extracto de raz de Panax ginseng 0.08%, sucralosa, acesulfamo K, cido srbico, cido benzoico, cafena 0.03%, L-carnitina L-tartrato 0.015%, niacina, cido pantotnico, B6, B12, cloruro sdico, D-glucoronolactona, extracto de semilla de guaran 0.002%, inositol Environment Green-Score not applicable Not yet applicable for the category: Energy drinks The Green-Score is not yet applicable for this category, but we are working on adding support for it
Rahrmann EP, Moriarity BS, Otto GM, Watson AL, Choi K, Collins MH, et al
